Login to Your Account


ZS Pharma ends streak of below-range IPO pricings, adds $107M

By Jennifer Boggs
Managing Editor

Thursday, June 19, 2014
Following the recent spate of scaled-back initial public offerings (IPOs) from the likes of Radius Health, Agile Therapeutics Inc., Aldeyra Therapeutics Inc. and Scynexis Inc., this week's IPO pricing by ZS Pharma Inc. – and its warm reception on Wall Street – is impressive by comparison.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription